Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer

European Journal of Human Genetics

Volumn 19, Issue 3, 2011, Pages 307-312

  Van Roon, Eddy H J ^a,c   De Miranda, Noël F C C ^a   Van Nieuwenhuizen, Merlijn P ^a   De Meijer, Emile J ^a   Van Puijenbroek, Marjo ^a   Yan, Pearlly S ^b   Huang, Tim H M ^b   Van Wezel, Tom ^a   Morreau, Hans ^a   Boer, Judith M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b OHIO STATE UNIVERSITY   (United States)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

colorectal cancer; CTCF; DNA methylation; Lynch syndrome; PTPRG

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE GAMMA; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER SCREENING; CHROMATIN IMMUNOPRECIPITATION; COHORT ANALYSIS; COLON MUCOSA; CONTROLLED STUDY; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; GENE; GENE EXPRESSION; GENE LOCUS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; INTRONS; PROMOTER REGIONS, GENETIC; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 79951814625     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.187     Document Type: Article

References (42)

1. Grady WM, Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135: 1079-1099.
2. Hiltunen MO, Alhonen L, Koistinaho J et al: Hypermethylation of the APC (adeno-matous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 1997; 70: 644-648. (Pubitemid 27158441)
3. Khulan B, Thompson RF, Ye K et al: Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 2006; 16: 1046-1055. (Pubitemid 44162264)
4. Ibrahim AE, Thorne NP, Baird K et al: MMASS: an optimized array-based method for assessing CpG island methylation. Nucleic Acids Res 2006; 34: e136.
5. Huang TH, Perry MR, Laux DE: Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999; 8: 459-470. (Pubitemid 29097334)
6. Irizarry RA, Ladd-Acosta C, Carvalho B et al: Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008; 18: 780-790. (Pubitemid 351645068)
7. Weber M, Davies JJ, Wittig D et al: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005; 37: 853-862. (Pubitemid 41077111)
8. Schuebel KE, Chen W, Cope L et al: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007; 3: 1709-1723. (Pubitemid 47510263)
9. Suzuki H, Gabrielson E, Chen W et al: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141-149.
10. Down TA, Rakyan VK, Turner DJ et al: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 2008; 26: 779-785. (Pubitemid 351961453)
11. Meissner A, Mikkelsen TS, Gu H et al: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454: 766-770.
12. Irizarry RA, Ladd-Acosta C, Wen B et al: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41: 178-186.
13. Weber M, Hellmann I, Stadler MB et al: Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007; 39: 457-466. (Pubitemid 46514772)
14. Yan PS, Chen CM, Shi H et al: Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 2001; 61: 8375-8380. (Pubitemid 33131108)
15. Cross SH, Charlton JA, Nan X et al: Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994; 6: 236-244. (Pubitemid 24188619)
16. Isola J, DeVries S, Chu L et al: Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 1994; 145: 1301-1308. (Pubitemid 24378485)
17. Yan PS, Efferth T, Chen HL et al: Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods 2002; 27: 162-169. (Pubitemid 34757129)
18. Knijnenburg J, Szuhai K, Giltay J et al: Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet A 2005; 132: 36-40. (Pubitemid 40070558)
19. Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc S B-Methodol 1995; 57: 289-300.
20. Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431. (Pubitemid 35414532)
21. Larkin MA, Blackshields G, Brown NP et al: Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23: 2947-2948. (Pubitemid 350162903)
22. Tom Hall. BioEdit (URL: http://www.mbio.ncsu.edu/BioEdit/). 2008.
23. Bock C, Reither S, Mikeska T et al: BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005; 21: 4067-4068. (Pubitemid 41631851)
24. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
25. Nygren AO, Ameziane N, Duarte HM et al: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005; 33: e128.
26. Vandesompele J, De PK, Pattyn F et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
27. Kim TH, Abdullaev ZK, Smith AD et al: Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007; 128: 1231-1245. (Pubitemid 46427876)
28. Kuhn RM, Karolchik D, Zweig AS et al: The UCSC Genome Browser Database: update 2009. Nucleic Acids Res 2009; 37: D755-D761.
29. Hubbard TJ, Aken BL, Ayling S et al: Ensembl 2009. Nucleic Acids Res 2009; 37: D690-D697.
30. Alemayehu A, Sebova K, Fridrichova I: Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Genes Chromosomes Cancer 2008; 47: 906-914.
31. LaForgia S, Morse B, Levy J et al: Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 1991; 88: 5036-5040. (Pubitemid 21914678)
32. Wang Z, Shen D, Parsons DW et al: Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004; 304: 1164-1166. (Pubitemid 38661854)
33. Hou C, Zhao H, Tanimoto K et al: CTCF-dependent enhancer-blocking by alternative chromatin loop formation. Proc Natl Acad Sci USA 2008; 105: 20398-20403.
34. Witcher M, Emerson BM: Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 2009; 34: 271-284.
35. Tiwari VK, Baylin SB: Breaching the boundaries that safeguard against repression. Mol Cell 2009; 34: 395-397.
36. De La Rosa-Velazquez IA, Rincon-Arano H, itez-Bribiesca L et al: Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res 2007; 67: 2577-2585. (Pubitemid 46548943)
37. Xu J, Huo D, Chen Y et al: CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast Cancer Res Treat 2009.
38. Lai AY, Fatemi M, Dhasarathy A et al: DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas. J Exp Med 2010; 207: 1939-1950.
39. Van Doorn R, Zoutman WH, Dijkman R et al: Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2005; 23: 3886-3896. (Pubitemid 46218691)
40. Furuta J, Nobeyama Y, Umebayashi Y et al: Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 2006; 66: 6080-6086.
41. Wang JF, Dai DQ: Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol 2007; 13: 5692-5698.
42. Lewis A, Murrell A: Genomic imprinting: CTCF protects the boundaries. Curr Biol 2004; 14: R284-R286. (Pubitemid 38458941)